Amylyx Pharmaceuticals Inc (AMLX)
2.075
+0.08
(+3.75%)
USD |
NASDAQ |
May 03, 12:53
Amylyx Pharmaceuticals Shares Outstanding: 67.78M for Feb. 12, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 12, 2024 | 67.78M |
December 31, 2023 | 67.71M |
November 06, 2023 | 67.52M |
September 30, 2023 | 67.51M |
August 07, 2023 | 67.38M |
June 30, 2023 | 67.35M |
May 08, 2023 | 67.18M |
April 11, 2023 | 67.11M |
March 31, 2023 | 67.10M |
March 08, 2023 | 66.72M |
December 31, 2022 | 66.51M |
Date | Value |
---|---|
November 07, 2022 | 66.26M |
September 30, 2022 | 58.53M |
August 08, 2022 | 58.53M |
June 30, 2022 | 58.53M |
May 09, 2022 | 58.53M |
April 14, 2022 | 57.86M |
March 31, 2022 | 57.86M |
March 21, 2022 | 57.86M |
January 07, 2022 | 56.47M |
January 03, 2022 | 55.22M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
55.22M
Minimum
Jan 03 2022
67.78M
Maximum
Feb 12 2024
63.12M
Average
66.51M
Median
Dec 31 2022
Shares Outstanding Benchmarks
Cassava Sciences Inc | 43.23M |
iRhythm Technologies Inc | 30.98M |
Bristol-Myers Squibb Co | 2.027B |
Moderna Inc | 382.88M |
ACADIA Pharmaceuticals Inc | 164.77M |